Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase - PubMed (original) (raw)
. 2002 Apr 12;277(15):13331-7.
doi: 10.1074/jbc.M112029200. Epub 2002 Jan 28.
Affiliations
- PMID: 11815622
- DOI: 10.1074/jbc.M112029200
Free article
Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase
Ala Aoukaty et al. J Biol Chem. 2002.
Free article
Abstract
Natural killer (NK) cells express an activating receptor, 2B4, that enhances cellular cytotoxicity. Upon NK cell activation by ligation of 2B4, the intracellular domain of 2B4 associates with the X-linked lymphoproliferative disease (XLP) gene product, signaling lymphocytic activation molecule-associated protein/SH2D1A (SAP/SH2D1A). Defective intracellular association of 2B4 with mutated SAP/SH2D1A is likely to underlie the defects in cytotoxicity observed in NK cells from patients with XLP. We report here a role for phosphoinositide 3-kinase (PI3K) in the recruitment and association of SAP/SH2D1A to 2B4 in human NK cells. The activation of normal NK cells by ligation of 2B4 leads to the phosphorylation of 2B4, recruitment of SAP/SH2D1A, and association of the p85 regulatory subunit of PI3K. The inhibition of PI3K enzymatic activity with either wortmannin or LY294002 prior to 2B4 ligation does not alter the association of 2B4 with the p85 subunit but prevents the recruitment of SAP/SH2D1A to 2B4. In addition, PI3K inhibitors significantly diminish the cytotoxic function of primary NK cells. This observed inhibition of cytotoxicity, present in normal NK cells, was less apparent or absent in NK cells derived from a patient with XLP. These data indicate that the cytotoxicity of activated NK cells is mediated by the association of 2B4 and SAP/SH2D1A, and that this association is dependent upon the activity of PI3K.
Similar articles
- Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome.
Tangye SG, Phillips JH, Lanier LL, Nichols KE. Tangye SG, et al. J Immunol. 2000 Sep 15;165(6):2932-6. doi: 10.4049/jimmunol.165.6.2932. J Immunol. 2000. PMID: 10975798 - X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells.
Parolini S, Bottino C, Falco M, Augugliaro R, Giliani S, Franceschini R, Ochs HD, Wolf H, Bonnefoy JY, Biassoni R, Moretta L, Notarangelo LD, Moretta A. Parolini S, et al. J Exp Med. 2000 Aug 7;192(3):337-46. doi: 10.1084/jem.192.3.337. J Exp Med. 2000. PMID: 10934222 Free PMC article. - Defective NK cell activation in X-linked lymphoproliferative disease.
Benoit L, Wang X, Pabst HF, Dutz J, Tan R. Benoit L, et al. J Immunol. 2000 Oct 1;165(7):3549-53. doi: 10.4049/jimmunol.165.7.3549. J Immunol. 2000. PMID: 11034354 - 2B4: an NK cell activating receptor with unique specificity and signal transduction mechanism.
Nakajima H, Colonna M. Nakajima H, et al. Hum Immunol. 2000 Jan;61(1):39-43. doi: 10.1016/s0198-8859(99)00170-6. Hum Immunol. 2000. PMID: 10658976 Review. - X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein.
Schuster V, Kreth HW. Schuster V, et al. Immunol Rev. 2000 Dec;178:21-8. doi: 10.1034/j.1600-065x.2000.17819.x. Immunol Rev. 2000. PMID: 11213803 Review.
Cited by
- Lentiviral vectors for precise expression to treat X-linked lymphoproliferative disease.
Ayoub PG, Gensheimer J, Lathrop L, Juett C, Quintos J, Tam K, Reid J, Ma F, Tam C, McAuley GE, Brown D, Wu X, Zhang R, Bradford K, Hollis RP, Crooks GM, Kohn DB. Ayoub PG, et al. Mol Ther Methods Clin Dev. 2024 Aug 20;32(4):101323. doi: 10.1016/j.omtm.2024.101323. eCollection 2024 Dec 12. Mol Ther Methods Clin Dev. 2024. PMID: 39309261 Free PMC article. - From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary Immunodeficiencies.
Tabellini G, Patrizi O, Dobbs K, Lougaris V, Baronio M, Coltrini D, Plebani A, Badolato R, Notarangelo LD, Parolini S. Tabellini G, et al. Front Immunol. 2019 Jul 24;10:1757. doi: 10.3389/fimmu.2019.01757. eCollection 2019. Front Immunol. 2019. PMID: 31396241 Free PMC article. Review. - Phosphoinositide-3-Kinase Signaling in Human Natural Killer Cells: New Insights from Primary Immunodeficiency.
Mace EM. Mace EM. Front Immunol. 2018 Mar 7;9:445. doi: 10.3389/fimmu.2018.00445. eCollection 2018. Front Immunol. 2018. PMID: 29563913 Free PMC article. Review. - Epstein-Barr Virus Susceptibility in Activated PI3Kδ Syndrome (APDS) Immunodeficiency.
Carpier JM, Lucas CL. Carpier JM, et al. Front Immunol. 2018 Jan 16;8:2005. doi: 10.3389/fimmu.2017.02005. eCollection 2017. Front Immunol. 2018. PMID: 29387064 Free PMC article. Review. - Biochemical and Functional Insights into the Integrated Regulation of Innate Immune Cell Responses by Teleost Leukocyte Immune-Type Receptors.
Fei C, Pemberton JG, Lillico DM, Zwozdesky MA, Stafford JL. Fei C, et al. Biology (Basel). 2016 Mar 8;5(1):13. doi: 10.3390/biology5010013. Biology (Basel). 2016. PMID: 27005670 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous